John Ridden

Title: John Ridden: Innovator in Nanoparticle Technology

Introduction

John Ridden is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of nanoparticle technology, particularly in the treatment of fungal infections. With a total of 5 patents to his name, Ridden's work showcases his dedication to advancing medical treatments through innovative solutions.

Latest Patents

Ridden's latest patents include groundbreaking compositions and methods for treating fungal infections. One of his notable inventions involves nanoparticles formed of a polymer and an antifungal agent. This invention specifically targets fungal nail and skin infections, utilizing a polymer selected from a group that includes linear or branched or cyclic polymonoguanide/polyguanidine and polybiguanide. Another significant patent focuses on a composition for treating onychomycosis and tinea pedis, which incorporates terbinafine. This composition is designed to be administered topically, providing a precise daily dose of terbinafine to the affected areas.

Career Highlights

Throughout his career, John Ridden has worked with various companies, including Blueberry Therapeutics Limited. His innovative approach and expertise in nanoparticle technology have positioned him as a key figure in the development of effective treatments for fungal infections.

Collaborations

Ridden has collaborated with notable professionals in his field, including Michael Davies and Liam Good. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

John Ridden's contributions to nanoparticle technology and his innovative patents reflect his commitment to improving medical treatments for fungal infections. His work continues to inspire advancements in the field, showcasing the importance of innovation in healthcare.